Prognostic value of systemic inflammatory response markers in cervical cancer

References

• Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. 2020. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet. Global Health 8:e191–e203.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68:394–424.
   PubMed Web of Science ®Google Scholar
• Bun A, Fujimoto Y, Higuchi T, Sata A, Fukui R, Ozawa H, et al. 2020. Prognostic significance of neutrophil-to-lymphocyte ratio in luminal breast cancers with low levels of tumour-infiltrating lymphocytes. Anticancer Research 40:2871–2880.
   PubMed Web of Science ®Google Scholar
• Ceran MU, Tasdemir U, Colak E, Güngör T. 2019. Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? A survival analysis. Journal of Ovarian Research 12:16.
   PubMed Web of Science ®Google Scholar
• Chao B, Ju X, Zhang L, Xu X, Zhao Y. 2020. A novel prognostic marker systemic inflammation response ındex (SIRI) for operable cervical cancer patients. Frontiers in Oncology 10:766.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang F, Sheng XG, Zhang SQ. 2015. Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1-IIa cervical cancer patients who undergo radical surgery. Onco Targets and Therapy 8:1355–1362.
   Google Scholar
• Chen L, Zhang F, Sheng XG, Zhang SQ, Chen YT, Liu BW. 2016. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil:lymphocyte. Medicine 95:e4381.
   PubMed Web of Science ®Google Scholar
• Cömert GK, Türkmen O, Kar İ, Sınacı S, Yılmaz Ergani S, Karalök A, et al. 2018. Independent predictors of survival in endometrium cancer: platelet-to-lymphocyte ratio and platelet/neutrophil/monocyte-to-lymphocyte ratio. Journal of the Turkish German Gynecological Association 19:78–86.
   PubMed Web of Science ®Google Scholar
• Copie-Bergman C, Gaulard P, Lavergne-Slove A, Brousse N, Fléjou JF, Dordonne K, et al. 2003. Proposal for a new histological grading system for post-treatment evaluation of gastric malt lymphoma. Gut 52:1656.
   PubMed Web of Science ®Google Scholar
• Criscitiello C, Esposito A, Trapani D, Curigliano G. 2016. Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer. Cancer Treatment Reviews 50:205–207.
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. 2014. Cancer-related inflammation and treatment effectiveness. The Lancet. Oncology 15:e493–e503.
   PubMed Web of Science ®Google Scholar
• Diefenhardt M, Hofheinz RD, Martin D, Beißbarth T, Arnold D, Hartmann A, et al. 2019. Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial. International Journal of Cancer 145:2282–2291.
   PubMed Web of Science ®Google Scholar
• Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. 2013. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nature Reviews. Cancer 13:759–771.
   PubMed Web of Science ®Google Scholar
• Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S. 2013. Tumor associated macrophages and neutrophils in cancer. Immunobiology 218:1402–1410.
   PubMed Web of Science ®Google Scholar
• Huang Q-T, Man Q-Q, Hu J, Yang Y-L, Zhang Y-M, Wang W, et al. 2017. Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis of observational studies. Oncotarget 8:16755–16764.
   PubMedGoogle Scholar
• Huang H, Liu Q, Zhu L, Zhang Y, Lu X, Wu Y, et al. 2019. Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer. Scientific Reports 9:3284.
   PubMed Web of Science ®Google Scholar
• Jablonska E, Puzewska W, Grabowska Z, Jablonski J, Talarek L. 2005. VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer. Cytokine 30:93–99.
   PubMed Web of Science ®Google Scholar
• Jonska-Gmyrek J, Gmyrek L, Zolciak-Siwinska A, Kowalska M, Fuksiewicz M, Kotowicz B. 2018. Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients. Cancer Management and Research 10:6029–6038.
   PubMed Web of Science ®Google Scholar
• Lee WC, Wu TJ, Chou HS, Yu MC, Hsu PY, Hsu HY, et al. 2012. The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery 151:213–222.
   PubMed Web of Science ®Google Scholar
• Li C, Liu W, Cheng Y. 2016. Prognostic significance of metastatic lymph node ratio in squamous cell carcinoma of the cervix. OncoTargets and Therapy 9:3791–3797.
   PubMed Web of Science ®Google Scholar
• Li MX, Liu XM, Zhang XF, Zhang JF, Wang WL, Zhu Y, et al. 2014. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. International Journal of Cancer 134:2403–2413.
   PubMed Web of Science ®Google Scholar
• Li YX, Chang JY, He MY, Wang HR, Luo DQ, Li FH, et al. 2021. Neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) predict clinical outcome in patients with Stage IIB cervical cancer. Journal of Oncology 2021:2939162.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhao R, Cui Y, Zhou Y, Wu X. 2018. The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I–III colon cancer. Scientific Reports 8:9453.
   PubMed Web of Science ®Google Scholar
• Ma J-y, Ke L-c, Liu Q. 2018. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer. Medicine 97:e12897.
   PubMed Web of Science ®Google Scholar
• Mangino G, Chiantore MV, Iuliano M, Fiorucci G, Romeo G. 2016. Inflammatory microenvironment and human papillomavirus-induced carcinogenesis. Cytokine & Growth Factor Reviews 30:103–111.
   PubMed Web of Science ®Google Scholar
• Mano Y, Aishima S, Fujita N, Tanaka Y, Kubo Y, Motomura T, et al. 2013. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma. Pathobiology 80:146–154.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. 2008. Cancer-related inflammation. Nature 454:436–444.
   PubMed Web of Science ®Google Scholar
• Mollinedo F. 2019. Neutrophil degranulation, plasticity, and cancer metastasis. Trends in Immunology 40:228–242.
   PubMed Web of Science ®Google Scholar
• Nuchpramool P, Hanprasertpong J. 2018. Preoperative neutrophil–lymphocyte ratio and platelet–lymphocyte ratio are not clinically useful in predicting prognosis in early stage cervical cancer. Surgery Research and Practice 2018:9162921.
   PubMedGoogle Scholar
• Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. 2011. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475:222–225.
   PubMed Web of Science ®Google Scholar
• Schlesinger M. 2018. Role of platelets and platelet receptors in cancer metastasis. Journal of Hematology and Oncology 11:125.
   PubMed Web of Science ®Google Scholar
• Stoiber D, Assinger A. 2020. Platelet–leukocyte interplay in cancer development and progression. Cells 9:855.
   PubMed Web of Science ®Google Scholar
• Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, et al. 2012. Paraneoplastic thrombocytosis in ovarian cancer. New England Journal of Medicine 366:610–618.
   PubMed Web of Science ®Google Scholar
• Tan D, Fu Y, Su Q, Wang H. 2016. Prognostic role of platelet–lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Medicine 95:e3837.
   PubMed Web of Science ®Google Scholar
• Tangjitgamol S, Katanyoo K, Laopaiboon M, Lumbiganon P, Manusirivithaya S, Supawattanabodee B, et al. 2014. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. Cochrane Database of Systematic Reviews 2014:CD010401.
   PubMed Web of Science ®Google Scholar
• Tavares-Murta BM, Mendonça MA, Duarte NL, da Silva JA, Mutão TS, Garcia CB, et al. 2010. Systemic leukocyte alterations are associated with invasive uterine cervical cancer. International Journal of Gynecological Cancer 20:1154–1159.
   PubMed Web of Science ®Google Scholar
• Vakkila J, Lotze MT. 2004. Inflammation and necrosis promote tumour growth. Nature Reviews. Immunology 4:641–648.
   PubMed Web of Science ®Google Scholar
• Wang Y-Y, Bai Z-L, He J-L, Yang Y, Zhao R, Hai P, et al. 2016. Prognostic value of neutrophil-related factors in locally advanced cervical squamous cell carcinoma patients treated with cisplatin-based concurrent chemoradiotherapy. Disease Markers 2016:1–9.
   Google Scholar
• Wang L, Jia J, Lin L, Guo J, Ye X, Zheng X, et al. 2017. Predictive value of hematological markers of systemic inflammation for managing cervical cancer. Oncotarget 8:44824–44832.
   PubMedGoogle Scholar
• Wang D, Wu M, Feng FZ, Huang HF, Yang JX, Shen K, et al. 2013. Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy. Chinese Medical Journal 126:1464–1468.
   PubMed Web of Science ®Google Scholar
• Wolny-Rokicka E, Brzeźniakiewicz-Janus K, Wydmański J, Tukiendorf A, Zembroń-Łacny A. 2018. Analysis of haemostasis biomarkers in patients with advanced stage lung cancer during hypofractionated radiotherapy treatment. Journal of International Medical Research 46:1876–1883.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang L, Liu Y, Wang S, Shang P, Gao Y, Chen X. 2014. Preoperative neutrophil–lymphocyte ratio before platelet–lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery. International Journal of Gynecological Cancer 24:1319–1325.
   PubMed Web of Science ®Google Scholar
• Zhu ML, Feng M, He F, Han BC, Ma K, Zeng XY, et al. 2018. Pretreatment neutrophil–lymphocyte and platelet–lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer. Clinica Chimica Acta 483:296–302.
   PubMed Web of Science ®Google Scholar
• Zou P, Yang E, Li Z. 2020. Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysis. Scientific Reports 10:21917.
   PubMed Web of Science ®Google Scholar